Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKD 8.42
(0.0%)
HKD 8.42
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.04 Billion HKD | -8.95% |
| 2022 | 1.15 Billion HKD | 2.73% |
| 2021 | 1.11 Billion HKD | 17.5% |
| 2020 | 952.9 Million HKD | -5.91% |
| 2019 | 1.01 Billion HKD | -6.09% |
| 2018 | 1.07 Billion HKD | 17.68% |
| 2017 | 916.43 Million HKD | 15.26% |
| 2016 | 795.08 Million HKD | 16.77% |
| 2015 | 680.87 Million HKD | 25.38% |
| 2014 | 543.03 Million HKD | 29.28% |
| 2013 | 420.04 Million HKD | 77.91% |
| 2012 | 236.09 Million HKD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 225.88 Million HKD | -16.37% |
| 2024 Q2 | 225.88 Million HKD | 0.0% |
| 2023 Q1 | 253.52 Million HKD | -29.34% |
| 2023 FY | 1.04 Billion HKD | -8.95% |
| 2023 Q3 | 270.09 Million HKD | 6.54% |
| 2023 Q2 | 253.52 Million HKD | 0.0% |
| 2023 Q4 | 270.09 Million HKD | 0.0% |
| 2022 Q3 | 358.81 Million HKD | -17.04% |
| 2022 Q4 | 358.81 Million HKD | 0.0% |
| 2022 Q1 | 216.25 Million HKD | -65.09% |
| 2022 Q2 | 432.51 Million HKD | 100.0% |
| 2022 FY | 1.15 Billion HKD | 2.73% |
| 2021 FY | 1.11 Billion HKD | 17.5% |
| 2021 Q2 | 500.15 Million HKD | 100.0% |
| 2021 Q3 | 309.73 Million HKD | -38.07% |
| 2021 Q4 | 619.46 Million HKD | 100.0% |
| 2021 Q1 | 250.07 Million HKD | -55.62% |
| 2020 Q1 | 194.68 Million HKD | -52.77% |
| 2020 Q2 | 389.37 Million HKD | 100.0% |
| 2020 Q3 | 281.76 Million HKD | -27.64% |
| 2020 FY | 952.9 Million HKD | -5.91% |
| 2020 Q4 | 563.52 Million HKD | 100.0% |
| 2019 Q4 | 412.19 Million HKD | 100.0% |
| 2019 Q2 | 600.6 Million HKD | 100.0% |
| 2019 Q1 | 300.3 Million HKD | 13.26% |
| 2019 Q3 | 206.09 Million HKD | -65.68% |
| 2019 FY | 1.01 Billion HKD | -6.09% |
| 2018 Q4 | 265.15 Million HKD | 0.0% |
| 2018 Q3 | 265.15 Million HKD | 0.4% |
| 2018 Q2 | 264.08 Million HKD | -7.02% |
| 2018 FY | 1.07 Billion HKD | 17.68% |
| 2018 Q1 | 284.02 Million HKD | 21.32% |
| 2017 Q3 | 222.22 Million HKD | -0.04% |
| 2017 FY | 916.43 Million HKD | 15.26% |
| 2017 Q2 | 222.32 Million HKD | -6.5% |
| 2017 Q4 | 234.11 Million HKD | 5.35% |
| 2017 Q1 | 237.77 Million HKD | 19.44% |
| 2016 Q4 | 199.07 Million HKD | 1.71% |
| 2016 FY | 795.08 Million HKD | 16.77% |
| 2016 Q3 | 195.72 Million HKD | -4.3% |
| 2016 Q2 | 204.51 Million HKD | 4.47% |
| 2016 Q1 | 195.76 Million HKD | 4.21% |
| 2015 Q2 | 174.06 Million HKD | 12.28% |
| 2015 Q4 | 187.84 Million HKD | 14.6% |
| 2015 Q3 | 163.92 Million HKD | -5.83% |
| 2015 Q1 | 155.03 Million HKD | -5.08% |
| 2015 FY | 680.87 Million HKD | 25.38% |
| 2014 Q3 | 124.31 Million HKD | -11.13% |
| 2014 Q2 | 139.88 Million HKD | 21.12% |
| 2014 Q1 | 115.49 Million HKD | -11.18% |
| 2014 FY | 543.03 Million HKD | 29.28% |
| 2014 Q4 | 163.34 Million HKD | 31.39% |
| 2013 Q1 | 86.24 Million HKD | 5.25% |
| 2013 FY | 420.04 Million HKD | 77.91% |
| 2013 Q2 | 106.97 Million HKD | 24.04% |
| 2013 Q3 | 96.79 Million HKD | -9.52% |
| 2013 Q4 | 130.03 Million HKD | 34.35% |
| 2012 FY | 236.09 Million HKD | 0.0% |
| 2012 Q4 | 81.93 Million HKD | 31.84% |
| 2012 Q1 | 41.63 Million HKD | 0.0% |
| 2012 Q2 | 50.37 Million HKD | 20.99% |
| 2012 Q3 | 62.15 Million HKD | 23.39% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| China Healthwise Holdings Limited | 60.29 Million HKD | -1636.894% |
| Tycoon Group Holdings Limited | 301.24 Million HKD | -247.638% |